Monoclonal Mouse anti‑Influenza A Virus Influenza A Virus Matrix Protein Antibody (PE, IHC, IF, WB) LS‑C655112
Monoclonal Mouse anti‑Influenza A Virus Influenza A Virus Matrix Protein Antibody (PE, IHC, IF, WB) LS‑C655112
Antibody:
Influenza A Virus Matrix Protein Mouse anti-Influenza A Virus Monoclonal (PE) Antibody
Reactivity:
Influenza A Virus
Format:
Phycoerythrin, Unmodified
Overview
Antibody:
Influenza A Virus Matrix Protein Mouse anti-Influenza A Virus Monoclonal (PE) Antibody
Reactivity:
Influenza A Virus
Format:
Phycoerythrin, Unmodified
Specifications
Description
Influenza A Virus Matrix Protein antibody LS-C655112 is a PE-conjugated mouse monoclonal antibody to influenza a virus Influenza A Virus Matrix Protein. Validated for IF, IHC and WB.
Target
Influenza A Virus Matrix Protein
Reactivity
Influenza A Virus
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Phycoerythrin.
Also available conjugated with
Biotin,
FITC,
HRP.
Purification
Protein A purified
Immunogen
Influenza A / Puerto Rico / 8 / 34 (H1N1) and A/Bangkok / 1 / 79 (H3N2) viruses.
Specificity
Recognizes the Influenza A matrix protein.
Applications
- IHC
- Immunofluorescence
- Western blot
- Applications tested for the base form of this product only
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Virus
Applications:
IHC - Paraffin, Immunofluorescence, Western blot
Species:
Influenza Virus
Applications:
Immunofluorescence
Species:
Influenza Virus
Applications:
Immunofluorescence
Source:
E. coli
Tag:
His-GST
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/25/2024